Use of DNA‐alkylating pyrrole‐imidazole polyamides for anti‐cancer drug sensitivity screening in pancreatic ductal adenocarcinoma-Reference-Cited by-同舟云学术

Use of DNA‐alkylating pyrrole‐imidazole polyamides for anti‐cancer drug sensitivity screening in pancreatic ductal adenocarcinoma

Published:2022-10-19 Issue:5 Volume:12 Page:5821-5832
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Medicine

Author:

Tsujimoto Akiko¹²,Matsuo Niina²³,Lai Xiaoyi¹²,Inoue Takahiro²³,Yoda Hiroyuki¹³^ORCID,Lin Jason³,Shinozaki Yoshinao³,Watanabe Takayoshi¹,Koshikawa Nobuko³,Takatori Atsushi¹^ORCID,Nagase Hiroki²³

Affiliation:

1. Division of Innovative Cancer Therapeutics Chiba Cancer Center Research Institute Chiba Japan

2. Graduate School of Medical and Pharmaceutical Sciences Chiba University Chiba Japan

3. Division of Cancer Genetics Chiba Cancer Center Research Institute Chiba Japan

Funder

Japan Agency for Medical Research and Development

Japan Society for the Promotion of Science

Ministry of Education, Culture, Sports, Science and Technology

Princess Takamatsu Cancer Research Fund

Takeda Science Foundation

Publisher

Wiley

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cam4.5359

Reference42 articles.

1. FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer

2. Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine

3. Pancreatic cancer

4. Durvalumab With or Without Tremelimumab for Patients With Metastatic Pancreatic Ductal Adenocarcinoma

5. Integrated genomic characterization of pancreatic ductal adenocarcinoma;Cancer Genome Atlas Research Network;Cancer Cell,2017

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nucleic acid‐based small molecules as targeted transcription therapeutics for immunoregulation;Allergy;2023-12-06